Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells

Journal of General Virology

Volumn 91, Issue 8, 2010, Pages 1959-1970

  Funke, Carsten ^a   Farr, Martin ^a   Werner, Bianca ^a   Dittmann, Sven ^a   Überla, Klaus ^b   Piper, Cornelia ^a   Niehaus, Karsten ^c   Horstkotte, Dieter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c BIELEFELD UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BOSENTAN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; ENDOTHELIN 1 TYPE A RECEPTOR; ENDOTHELIN 1 TYPE B RECEPTOR; ENDOTHELIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG; VALSARTAN; ANTIVIRUS AGENT; COXSACKIE-ADENOVIRUS RECEPTOR; DRUG DERIVATIVE; SULFONAMIDE; TETRAZOLE DERIVATIVE; VALINE; VIRUS RECEPTOR;

ADENOVIRUS INFECTION; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DRUG EFFECT; ENDOTHELIUM CELL; EPITHELIUM CELL; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; HEART MUSCLE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; VIRUS LOAD; VIRUS STRAIN; WESTERN BLOTTING; BIOSYNTHESIS; DOWN REGULATION; DRUG ANTAGONISM; ENTEROVIRUS; HELA CELL; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ADENOVIRIDAE; COXSACKIEVIRUS; ENTEROVIRUS;

ANTIVIRAL AGENTS; DOWN-REGULATION; ENDOTHELIAL CELLS; ENTEROVIRUS B, HUMAN; EPITHELIAL CELLS; GENE EXPRESSION; HELA CELLS; HUMANS; RECEPTORS, VIRUS; RNA, MESSENGER; SULFONAMIDES; TETRAZOLES; VALINE; VIRAL LOAD; VIRUS REPLICATION;

EID: 77955298984     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.020065-0     Document Type: Article

References (39)

1. Abelmann, W. H. (1973). Viral myocarditis and its sequelae. Annu Rev Med 24, 145-152.
2. Barst, R. J. (2007). A review of pulmonary arterial hypertension: role of ambrisentan. Vasc Health Risk Manag 3, 11-22. (Pubitemid 46860713)
3. Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L. & Finberg, R. W. (1997). Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323. (Pubitemid 27114163)
4. Bian, C., Wu, Y. & Chen, P. (2009). Telmisartan increases the permeability of endothelial cells through zonula occludens-1. Biol Pharm Bull 32, 416-420.
5. Bowles, N. E., Richardson, P. J., Olsen, E. G. & Archard, L. C. (1986). Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1, 1120-1123.
6. Carson, S. D. (2001). Receptor for the group B coxsackieviruses and adenoviruses: CAR. Rev Med Virol 11, 219-226.
7. Coyne, C. B., Shen, L., Turner, J. R. & Bergelson, J. M. (2007). Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2, 181-192. (Pubitemid 47355203)
8. Dec, G. W., Jr, Palacios, I. F., Fallon, J. T., Aretz, H. T., Mills, J., Lee, D. C. & Johnson, R. A. (1985). Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312, 885-890.
9. Dennert, R., Crijns, H. J. & Heymans, S. (2008). Acute viral myocarditis. Eur Heart J 29, 2073-2082.
10. Eckart, R. E., Scoville, S. L., Campbell, C. L., Shry, E. A., Stajduhar, K. C., Potter, R. N., Pearse, L. A. & Virmani, R. (2004). Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann InternMed 141, 829-834.
11. Freimuth, P., Philipson, L. & Carson, S. D. (2008). The coxsackievirus and adenovirus receptor. Curr Top Microbiol Immunol 323, 67-87.
12. Harada, M., Itoh, H., Nakagawa, O., Ogawa, Y., Miyamoto, Y., Kuwahara, K., Ogawa, E., Igaki, T., Yamashita, J. & other authors (1997). Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin- 1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 96, 3737-3744. (Pubitemid 27513456)
13. + T-cell responses in coxsackievirus B3-induced myocarditis in mice. J Virol 73, 4689-4695.
14. Ishikawa, K., Ihara, M., Noguchi, K., Mase, T., Mino, N., Saeki, T., Fukuroda, T., Fukami, T., Ozaki, S. & other authors (1994). Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A 91, 4892-4896. (Pubitemid 24177756)
15. Johansson, E. S., Xing, L., Cheng, R. H. & Shafren, D. R. (2004). Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21. J Virol 78, 12603-12612. (Pubitemid 39458778)
16. Kallewaard, N. L., Zhang, L., Chen, J. W., Guttenberg, M., Sanchez, M. D. & Bergelson, J. M. (2009). Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe 6, 91-98.
17. Kandolf, R., Ameis, D., Kirschner, P., Canu, A. & Hofschneider, P. H. (1987). In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A 84, 6272-6276.
18. Kingman, M., Ruggiero, R. & Torres, F. (2009). Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension. Expert Opin Pharmacother 10, 1847-1858.
19. Klump, W. M., Bergmann, I., Muller, B. C., Ameis, D. & Kandolf, R. (1990). Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 59 uridine residues are regained during plus-strand RNA synthesis. J Virol 64, 1573-1583. (Pubitemid 20104893)
20. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
21. Lim, B. K., Choi, J. H., Nam, J. H., Gil, C. O., Shin, J. O., Yun, S. H., Kim, D. K. & Jeon, E. S. (2006). Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovasc Res 71, 517-526.
22. Lisewski, U., Shi, Y., Wrackmeyer, U., Fischer, R., Chen, C., Schirdewan, A., Juttner, R., Rathjen, F., Poller, W. & other authors (2008). The tight junction protein CAR regulates cardiac conduction and cell-cell communication. J Exp Med 205, 2369-2379.
23. Mahrholdt, H., Wagner, A., Deluigi, C. C., Kispert, E., Hager, S., Meinhardt, G., Vogelsberg, H., Fritz, P., Dippon, J. & other authors (2006). Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114, 1581-1590. (Pubitemid 44547428)
24. Marchant, D., Dou, Y., Luo, H., Garmaroudi, F. S., McDonough, J. E., Si, X., Walker, E., Luo, Z., Arner, A. & other authors (2009). Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditis. Circ Res 104, 813-821.
25. Martino, T. A., Petric, M., Weingartl, H., Bergelson, J. M., Opavsky, M. A., Richardson, C. D., Modlin, J. F., Finberg, R. W., Kain, K. C. & other authors (2000). The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 271, 99-108. (Pubitemid 30341519)
26. Milting, H., Kassner, A., Arusoglu, L., Meyer, H. E., Morshuis, M., Brendel, R., Klauke, B., El Banayosy, A. & Korfer, R. (2006). Influence of ACE-inhibition and mechanical unloading on the regulation of extracellular matrix proteins in the myocardium of heart transplantation candidates bridged by ventricular assist devices. Eur J Heart Fail 8, 278-283. (Pubitemid 43674485)
27. Noutsias, M., Fechner, H., de Jonge, H., Wang, X., Dekkers, D., Houtsmuller, A. B., Pauschinger, M., Bergelson, J., Warraich, R. & other authors (2001). Human coxsackie-adenovirus receptor is colocalized with integrins αvβ3 and αvβ5 on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 104, 275-280. (Pubitemid 32666947)
28. Nuedling, S., van Eickels, M., Allera, A., Doevendans, P., Meyer, R., Vetter, H. & Grohe, C. (2003). 17β-Estradiol regulates the expression of endothelin receptor type B in the heart. Br J Pharmacol 140, 195-201. (Pubitemid 37175845)
29. Okada, M. & Nishikibe, M. (2002). BQ-788, a selective endothelin ET(B) receptor antagonist. Cardiovasc Drug Rev 20, 53-66. (Pubitemid 34651322)
30. Ono, K., Matsumori, A., Shioi, T., Furukawa, Y. & Sasayama, S. (1999). Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: acute effects of Bosentan, an endothelin receptor antagonist. Circulation 100, 1823-1829. (Pubitemid 29498390)
31. Patel, K. P., Coyne, C. B. & Bergelson, J. M. (2009). Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells. J Virol 83, 11064-11077.
32. Pinkert, S., Westermann, D., Wang, X., Klingel, K., Dorner, A., Savvatis, K., Grossl, T., Krohn, S., Tschope, C. & other authors (2009). Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor. Circulation 120, 2358-2366.
33. Pong, R. C., Lai, Y. J., Chen, H., Okegawa, T., Frenkel, E., Sagalowsky, A. & Hsieh, J. T. (2003). Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells. Cancer Res 63, 8680-8686. (Pubitemid 38064044)
34. Shi, Y., Chen, C., Lisewski, U., Wrackmeyer, U., Radke, M., Westermann, D., Sauter, M., Tschope, C., Poller, W. & other authors (2009). Cardiac deletion of the coxsackievirus-adenovirus receptor abolishes coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol 53, 1219-1226.
35. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J. & Klenk, D. C. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150, 76-85.
36. Tomko, R. P., Xu, R. & Philipson, L. (1997). HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 94, 3352-3356. (Pubitemid 27157315)
37. Yajima, T. & Knowlton, K. U. (2009). Viral myocarditis: from the perspective of the virus. Circulation 119, 2615-2624.
38. Yanagawa, B., Spiller, O. B., Proctor, D. G., Choy, J., Luo, H., Zhang, H. M., Suarez, A., Yang, D. & McManus, B. M. (2004). Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice. J Infect Dis 189, 1431-1439. (Pubitemid 38543592)
39. Zautner, A. E., Korner, U., Henke, A., Badorff, C. & Schmidtke, M. (2003). Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J Virol 77, 10071-10077. (Pubitemid 37122088)